Dysfunctional clinical outcomes following spinal cord injury (SCI) result from glial scar
formation, leading to the inhibition of new axon growth and impaired regeneration …

The harsh local micro-environment following spinal cord injury (SCI) remains a great
challenge for neural regeneration. Local reconstitution of a favorable micro-environment by …

Hydrogel‐based regenerated scaffolds show promise as a platform for neural regeneration
following spinal cord injury (SCI). Nevertheless, the persistent problem of poor mechanical …

Background Traumatic spinal cord injury (SCI) causes neuronal death, demyelination,
axonal degeneration, inflammation, glial scar formation, and cystic cavitation resulting in …

Hydrogel scaffolds which bridge the lesion, together with stem cell therapy represent a
promising approach for spinal cord injury (SCI) repair. In this study, a hydroxyphenyl …

Spinal cord injury (SCI) often causes neuronal death and axonal degeneration. In this study,
we report a new strategy for preparing injectable and conductive polysaccharides-based …

Acidic fibroblast growth factor (aFGF) exerts a protective effect on spinal cord injury (SCI) but
is limited by the lack of physicochemical stability and the ability to cross the blood spinal …

Local reconstruction of a permissive environment with biomaterials is a promising strategy to
treat spinal cord injury (SCI). We reported a hybrid hydrogel fabricated from a small …

Extensive tissue engineering studies have supported the enhanced spinal cord
regeneration by implantable scaffolds loaded with bioactive cues. However, scaffolds with …

Sensorimotor functional recovery after spinal cord injury (SCI) is still a large challenge in the
clinic. Cabazitaxel (Cab) is a microtubule inhibitor approved by the FDA in 2010 for …